Yale Podnos
Chief Medical Officer at Oncology Institute, Inc. (STLN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $277K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 16SEC | STLNOncology Institute, Inc. | Sell Plan | 17,974259,527 held (−6%) | $6.43 | $116K | +0.0% |
| Jul 16SEC | STLNOncology Institute, Inc. | Sell Plan | 5,478259,527 held (−2%) | $6.35 | $35K | +1.3% |
| Jun 9SEC | STLNOncology Institute, Inc. | Sell Plan | 23,451259,527 held (−8%) | $5.38 | $126K | +19.5% |
- Sell
Chief Medical Officer Yale Podnos sold $116K of STLN at $6.43 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Yale Podnos sold $35K of STLN at $6.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Yale Podnos sold $126K of STLN at $5.38 — pre-scheduled 10b5-1 plan sale.